Overview of Progress in the Fluorocarbon Approach to in vivo Oxygen Delivery

References

• Blood Substitutes, T. M.S. Chang, R. P. Geyer. Marcel Dekker, New York 1989
   Google Scholar
• Geyer R. P. Perfluorochemicals as oxygen transport vehicles. 1989; 31–49, Ref. 1
   Google Scholar
• Perfluorochemical Oxygen Transport, K. K. Tremper. Little, Brown & C°, Boston 1985, Intl. Anesth. Clin. 23
   Google Scholar
• Proceed. Intl. Symp. Artificial Blood Substitutes (Ban, Italy, 1987), G. de Stasio, F. de Venuto, M. Lancieri. Servizio di Immunoentologia e Trasfusione, Bari 1987
   Google Scholar
• Blood Substitutes: Preparation, Physiology and Medical Applications, K. C. Lowe. Ellis Horwood Ltd, Chichester 1988
   Google Scholar
• Proceed. 2nd Intl. Symp. Red Cell Substitutes (Sapporo, Japan, 1989), S. Sekiguchi. Kindai shuppan, Tokyo 1991
   Google Scholar
• Riess J. G., Le Blanc M. Perfluorocompounds as blood substitutes. Angew. Chem. Intl Ed. Engl. 1978; 621–634
   PubMed Web of Science ®Google Scholar
• Le Blanc M., Riess J. G. Artificial blood substitutes based on perfluorochemicals. Preparation, Properties and Industrial Applications of Organofluorine Compounds, R.E. Banks. Ellis Horwood, ChichesterUK 1982; 83–136
   Google Scholar
• Riess J. G., Le Blanc M. Preparation of perfluorochemical emulsions for biomedical use: Principles, materials and methods. 1988; 94–129, Ref. 5, Chap. 5
   Google Scholar
• Riess J. G. Blood substitutes: Where do we stand with the fluorocarbon approach?. Curr. Surg. 1988; 45: 365–370
   PubMedGoogle Scholar
• Riess J.G. Fluorocarbon-based blood substitutes: what progress?. J. Artif. Org. 1991; 14: 255–258, Editorials
   Web of Science ®Google Scholar
• Riess J. G. “Synthetic fluorocarbon-based oxygen-transport fluids”. Vox Sang. 1991; 61: 225–239
   PubMed Web of Science ®Google Scholar
• Riess J. G., Le Blanc M. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure & Appl. Chem. 1982; 54: 2382–2406
   Web of Science ®Google Scholar
• Riess J. G. Reassessment of criteria for the selection of perfluorochemicals for second generation blood substitutes: analysis of structure/property relationships. Artif. Org 1984; 8: 44–56
   PubMed Web of Science ®Google Scholar
• Burgan A.R., Herrick W.C., Long D.M., Long D. C. Acute and subacute toxicity of 100% PFOB emulsion. 1989; 681–682, Ref. 1
   Google Scholar
• Mitten R.M., Burgan A.R., Hamblin A., Yee G., Long D.C., Long D.M., Mattrey R.F. Dose related biodistribution & elimination of 100% PFOB emulsion. ibid 1989; 683–684
   Google Scholar
• Long D.M., Long D.C., Mattrey R.F., Long R.A., Burgan A.R., Herrick W. C., Shellhamer D. F. An overview of perfluoroctylbromide—application as a synthetic oxygen carrier and imaging agent for X-ray, ultrasound and nuclear magnetic resonance. 1989; 411–420, Ref. 1
   Google Scholar
• Long D.M., Higgins C.B., Mattrey R.F., Mitten R.M., Multer F. K. chap. 4. Is there a time and place for radiopaque fluorocarbons?. Preparation, Properties and Industrial Applications of Organofluorine Compounds, R.E. Banks. Ellis Horwood, ChichesterUK 1982; 139–156
   Google Scholar
• Fluosol, package insert 1989. The Green Cross Corp., OsakaJapan
   Google Scholar
• Beloyartsev F. F., Mayevsky E.I., Islamov B. I. Ftorosan-oxygen carrying perfluorochemical plasma substitute. Acad. Sci. USSR Pushchino 1983
   Google Scholar
• Islamov B.I., Ladilov Iu. V., Buevich V.A., Bobrovskioi R.V. An emulsion of fluorocarbons as a protective agent against myocardial ischemia. Vestn. Akad. Med. Nauk SSSR 1991; 3: 39–43
   Google Scholar
• H-Chen S., Z-Yang H., et al. Perfluorocarbon as blood substitute in clinical applications and in war casualties. 1989; 403–410, Ref. 1
   Google Scholar
• Biro G. P., Blais P. Perfluorocarbon blood substitutes. CRC Crit. Rev. Oncol./Hematol. 1987; 6: 311–374
   PubMed Web of Science ®Google Scholar
• Long D. C.D., Long M.J., Riess G., Follana R., Burgan A., Mattrey R. F. Preparation and application of highly concentrated perfluoroctylbromide fluorocarbon emulsions. 1989; 441–442, Ref. 1
   Google Scholar
• Arlen C., Follana R., Le Blanc M., Long C., Long D., Riess J.G., Valla A. Formulation of highly concentrated fluorocarbon emulsions and assessment of near-total exchange perfusion of the conscious rat. ibid. 1989; 455–457
   Google Scholar
• Mattrey R. F. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs. Crit. Care Med. 1989; 17: 652–656
   PubMed Web of Science ®Google Scholar
• Ramrakhyani K., Millard R. W. Interspecies hcmodynamic and hematologic responses to Oxygent™ HT, a fluorochemical emulsion. These Proceedings, ISBS 1991; 471, Abstracts
   Google Scholar
• Follana R., Klein D., Krafft M.-P., Long D.M., Long D.C., Riess J.G., Valla A. Prolonged shelf-life and biocompatibility of a concentrated injectable fluorocarbon emulsion. These Proceedings, ISBS 1991; 384, Abstracts
   Google Scholar
• Riess J.G., Dalfors J.L., Hanna G.K., Klein D.H., Krafft M.-P., Pelura T.J., Schutt E.G. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. These Proceedings, ISBS 1991; 475, Abstracts
   Google Scholar
• Riess J. G., Krafft M.-P. Elaboration of fluorocarbon emulsions with improved oxygen-carrying capabilities. Oxygen Transport to Tissues XIV, W. Erdmann, D.F. Bruley. Plenum PubL Corp., New York, in press
   Google Scholar
• Pelura T.J., Johnson C.S., Tarara T.E. Stabilization of perfluorooctylbromide emulsions with egg yolk phospholipid. These Proceedings, ISBS 1991; 462, Abstracts
   Google Scholar
• Hanna G.K., Ojeda M.C., Sklenar T. A. Application of computer-based experimental design to optimization of processing conditions for perfluorocarbon emulsion. These Proceedings, ISBS 1991; 391, Abstracts
   Google Scholar
• Dalfors J. L. Terminal sterilization of perfluorocarbon (PFC) emulsions: Difficulties and possible solutions. These Proceedings, ISBS 1991; 371, Abstracts
   Google Scholar
• Klein D.H., Burtner D.B., Trevino L.A., Arlauskas R.A. Particle size distribution of concentrated perfluorocarbon emulsions by sedimentation field flow fractionation. These Proceedings, ISBS 1991; 410, Abstracts
   Google Scholar
• Ni Y., Klein D.H., Pelura T.J. Rheology of concentrated perfluorocarbon emulsions. These Proceedings, ISBS 1991; 454, Abstracts
   Google Scholar
• Postel M., Chang P., Rolland J.-P., Krafft M.-P., Riess J. G. Fluorocarbon/lecithin emulsions: identification of EYP-coated fluorocarbon droplets and fluorocarbon-empty vesicles by freeze-fracture electron microscopy. Biochim. et Biophys. Acta 1991; 1086: 95–98
   PubMedGoogle Scholar
• Krafft M.-P., Rolland J.-P., Riess J. G. Detrimental effect of excess lecithin on the stability of fluorocarbon/lecithin emulsions. J. Phys. Chem. 1991; 95: 5673–5676
   Web of Science ®Google Scholar
• Ohyanagi H., Saitoh Y., Mitsuno T., Watanabe M., Yamanouchi K., Yokoyama K. A new perfluorochemical emulsion: An overview. Art. Organs 1990; 14: 199–200
   Google Scholar
• Uchida T., Ohtaki Y., Kido H., Watanabe M., Yokoyama K. Protective effect of FMIQ emulsion coronary perfusion on a myocardial ischemia model in an anesthetized open-chest dog. 1991; 2–4, Ref. 6
   Google Scholar
• Meinert H., Fackler R., Knoblich A., Mader J., Reuter P., Röhlke W. On the perfluorocarbon emulsions of second generation. These Proceedings, ISBS 1991; 438, Abstracts
   Google Scholar
• Riess J. G., Postel M. Stability and stabilization of fluorocarbon emulsions destined for injection. These Proceedings, ISBS 1991; 474, Abstracts
   Google Scholar
• Magdassi S., Royz M., Shoshan S. Chemical instability of phospholipids: a key factor in stabilization of perfluorocarbon emulsions. J. Disp. Sci. Technol. 1991; 12: 69–82
   Web of Science ®Google Scholar
• Davis S.S., Round H.P., Purewal T. S. Ostwald ripening and the stability of emulsion systems: an explanation for the effect of an added third component. J. Colloid Interf. Sci. 1981; 80: 508–511
   Web of Science ®Google Scholar
• Kabalnov A.S., Aprosin Y.D., Pavlova-Verovkina O.B., Pertsov A.V., Shchukin R. D. Influence of nature and composition of disperse phase in emulsions of perfluoroorganic compounds on the kinetics of the decrease in emulsion dispersity. Kolloidn. Zh. 1986; 48: 27–32
   Google Scholar
• Sharma S.K., Lowe K.C., Davis S. S. Novel compositions of emulsified perfluorochemicals for biological uses. 1989; 447–450, Ref. 1
   Google Scholar
• Cecutti C., Rico I., Lattes A., Novelli A., Rico A., Marion G., Gracia A., Lachaise J. New formulation of blood substitutes: optimization of novel fluorinated microemulsions. Eur. J. Med. Chem. 1989; 24: 485–492
   Web of Science ®Google Scholar
• Riess J. G. Fluorocarbon-based oxygen carriers: New orientations. Art. Ore. 1991; 15: 408–413
   PubMed Web of Science ®Google Scholar
• Riess J. G. Fluorocarbon emulsions for in vivo oxygen delivery. The decisive role expected of the surfactant in future progress. Proc. 2^nd World Surfactant Congress 1988; 4: 256–263
   Google Scholar
• Zarif L., Greiner J., Pace S., Riess J. G. Synthesis of perfluoroalkyl xylitol ethers and esters: New surfactants for biomedical uses. J. Med. Chem. 1990; 33: 1262–1269
   PubMed Web of Science ®Google Scholar
• Greiner J., Manfredi A., Riess J. G. Synthesis and preliminary evaluation of 2-(F-alkyl)-ethyl glycosides, a series of new F-alkylated surfactants for in vivo uses. New J. Chem. 1989; 13: 247–254
   Web of Science ®Google Scholar
• Zarif L., Manfredi A., Varescon C., Le Blanc M., Riess J.G. Synergistic stabilization of perfluorocarbon-Pluronic F-68 emulsion by perfluoroalkylated polyhydroxylated surfactants. JAOCS 1989; 66: 1515–1523
   Web of Science ®Google Scholar
• Milius A., Greiner J., Riess J. G. Improvement in emulsification ease, particle size reduction and stabilization of concentrated fluorocarbon emulsions by small amounts of (D-glucosyl)[2-(perfluoroalkyl)ethyl] phosphates as surfactants. Colloids and Surfaces, in press
   Google Scholar
• Nivet J.-B., Le Blanc M., Riess J. G. Synthesis and preliminary evaluation of perfluoroalkylacyl carnitines as surfactants for biomedical uses. Eur. J. Med. Chem., in press
   Google Scholar
• Krafft M.-P., Rolland J.-P., Vierling P., Riess J. G. New perfluoroalkylated phosphocholines. Effects on particle size and stability of fluorocarbon emulsions. New J. Chem. 1990; 14: 869–875
   Web of Science ®Google Scholar
• Santaella Vierling C.P., Riess J.G. New perfluoroalkylated phospholipids as injectable amphiphiles: Synthesis, preliminary physicochemical and biocompatibility data. New J. Chem. 1991; 15: 685–692
   Web of Science ®Google Scholar
• Pavia A.A., Pucci B., Riess J.G., Zarif L. New fluorinated biocompatible non-ionic telomeric amphiphiles bearing trishydroxymethyl groups. Bioorg. & Med. Chem. Lett. 1991; 1: 103–106
   Web of Science ®Google Scholar
• Riess J.G., Pavia A.A., Pucci B., Zarif L. Telomeric tham-derived surfactants for injectable fluorocarbon emulsions. These Proceedings, ISBS 1991; 473, Abstracts
   Google Scholar
• Riess J. G., Pace S., Zarif L. Highly effective surfactants with low hemolytic activity. Adv. Mat. 1991; 3: 249–251
   Web of Science ®Google Scholar
• Mahe A. M., Manoux J., Valla A., Follana R., Zarif L., Greiner J., Vierling P., Riess J. G. Perfluoroalkylated surfactants: Relationships between structure and acute toxicity in mice. These Proceedings, ISBS 1991; 426, Abstracts
   Google Scholar
• Faithfull N. S. Potential applications of perfluorochemical emulsions in medicine and research, Ref. 5, Chap. 6
   Google Scholar
• Faithfull N.S. Artificial oxygen-carrying blood substitutes. Oxygen Transport to Tissues XIV, W. Erdmann, D.F. Bruley. Plenum Publ. Corp., New York, in press
   Google Scholar
• Lowe K. C. Synthetic oxygen transport fluids based on perfluorochemicals: Applications medicine and biology. Vox. Sang. 1991; 60: 129–140
   PubMed Web of Science ®Google Scholar
• Tremper K. K.E., Levine M., Waxman K. Clinical experience with Fluosol-DA (20%) in the United States. 185–197, Ref. 3
   Google Scholar
• Kent K. M. M., Cleman W. M. J., Cowley M. B., Forman C. C., Jaffe M., Kaplan S. P., King I, II, Krucoff M. W., Lasse T., McAuley B., Smith R., Wisdom C., Wohlgelemter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygentated Fluosol. Am. J. Cardiol. 1990; 66: 279–284
   PubMed Web of Science ®Google Scholar
• Forman M.B., Perry J.M., Wilson B.H., Verani M.S., Kaplan P.R., Shawl F.A., Friesinger G.C. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochamical in anterior myocardial infarction. J. Am. Coll. Cardiol. 1991; 18: 911–918
   PubMed Web of Science ®Google Scholar
• Bell M.R., Nishimura R.A., Holmes D.R., Bailey K.R., Schwartz R.S., Vlietstra R. E. Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?. J. Am. Coll. Cardiol. 1990; 16: 959–966
   PubMed Web of Science ®Google Scholar
• Cowley M.J., Snow F.R., Sciascio Si.G., Kelly K., Guard C., Nixon J. V. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients. Circulation 1990; 81: 27–34, suppl. IV
   Web of Science ®Google Scholar
• Evans R.G., Kimler B.F., Morantz R.A., Vats T.S., Gemer L.S., Liston V., Lowe N. A phase I/II study of the use of Fluosol® as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors. Ira. J. Radiation Oncology Biol. Phys. 1990; 19: 415–420
   PubMed Web of Science ®Google Scholar
• Lustig R., Lowe N., Prosnitz L., Spaulding M., Cohen M., Stitt J., Brannon R. Fluosol® and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: Results of a phase I/II study. Int. J. Radiation Oncology Biol. Phys. 1990; 19: 97–102
   PubMed Web of Science ®Google Scholar
• Gruber M., Prados M., Russel C., Hochberg F., Cook P., Weissman D., Evans R., Burton G., Allen D., Brannon R. Phase I/II study of Fluosol®/O2 in combination with BCNU in malignant glioma. Proc. Am. Assoc. Cancer Res. 1990; 31: 190
   Google Scholar
• Garewal H., Skarin A., Kessler J., Smith R., Hedberg J. Fluosol®/oxygen in combination with cyclophosphamide in advanced non-small cell lung carcinoma (NSCLC); phase I results. Proc. Am. Assoc. Cancer Res. 1989; 30: 271
   Google Scholar
• Meyers F., Albert D., Spaulding M., Garewal H., Flam M., Allen D. Phase I/II study of Fluosol®/oxygen in combination with weekly 5-fluorouracil (5FU) in metastatic colorectal carcinoma. Proc. Am. Assoc. Cancer Res. 1989; 30: 256
   Google Scholar
• Spence R. K., Mc S., Coy J., Costabile E. D., Norcross M. J., Pello J. B., Alexander C., Wisdom R. C. Camishion Fluosol DA-20 in the treatment of severe anemia: Randomized, controlled study of 46 patients. Crit. Care Med. 1990; 18: 1227–1230
   PubMed Web of Science ®Google Scholar
• Hogan M.C., Willford D.C., Wagner P. D. Effect of perfluorooctylbromide emulsion on O2 diffusing capacity of dog muscle working maximally in situ with low [Hb]. These Proceedings, ISBS 1991; 389, Abstracts
   Google Scholar
• Braun R.D., Goldstick T.K., Linsenmeier R. A. Concentrated perfluorooctylbromide emulsion diffusion increases tissue PO2 in normovolemic cats breathing 100% oxygen. These Proceedings. ISBS 1991; 360, Abstracts
   Google Scholar
• Biro B. P. Studies on blood substitutes based on hemoglobin and perfluorocarbon. These Proceedings, ISBS 1991; 356, Abstracts
   Google Scholar
• Haas N., Stewart L.C., Clarke K., Tian G.H., Scott J., Biro G.P., Deslauriers R. Myocardial contractile function in porcine hearts perfused with media containing erythrocytes or perfluoro-octylbromide. These Proceedings, ISBS 1991; 390, Abstracts
   Google Scholar
• Faithfull N. S., Cain S. M. Critical levels of O2 extraction following hemodilution with Dextran or Fluosol-DA. J. Crit. Care 1988; 3: 14–18
   Web of Science ®Google Scholar
• Faithfull N. S. Perfluorocarbons as blood substitutes—bulk oxygen delivery and diffusion facilitation. These Proceedings, ISBS 1991; 379, Abstracts
   Google Scholar
• Lutz J. Effect of perfluorochemicals on host defense, especially on the reticuloendothelial system. 63–93, Ref. 3
   Google Scholar
• Lane T. A., Lamkin G. E. Increased infection mortality and decreased neutrophil migration due to a component of an artificial blood substitute. Blood 1986; 68: 351–354
   PubMed Web of Science ®Google Scholar
• Lowe K. C. Biological assessment of perfluorochemical emulsions. 1988; 149–172, Ref. 5, Chap. 7
   Google Scholar
• Riess J. G. Hemocompatible fluorocarbon emulsions. Blood Compatible Materials and Devices: Perspectives towards the 21st Century, C.P. Sharma, M. Szycher. Technomic, Lancaster 1990
   Google Scholar
• Bottalico L.A., Betensky H.T., Min Y.B., Weinstock S.B. Perfluorochemical emulsions decrease Kupffer cell phagocytosis. Hepatology 1991; 14: 169–174
   PubMed Web of Science ®Google Scholar
• Bentley P.K., Johnson O.L., Washington C., Lowe K. C. Lymphoid tissue responsees to concentrated perfluorochemical emulsions. Biomat., Art. Cells. Immob. Biotech., 19: 353
   Google Scholar
• Lowe K.C. Biocompatibility studies with perfluorochemicals 1991. These Proceedings, ISBS 1991; 419, Abstracts
   Google Scholar
• Lowe K.C., Bentley P.K. Retention of perfluorochemicals in rat tissues. These Proceedings, ISBS 1991; 421, Abstracts
   Google Scholar
• Shrewsbury R. P., White L. G. Acute effects of moderate Fluosol-DA hemodilution on hepatic microsomal and nonmicrosomal metabolism in rats. These Proceedings, ISBS 1991; 485, 1991, Abstracts
   Google Scholar
• Mitsuno T., Ohyanagi H. Present status of clinical studies of Fluosol-DA (20%) in Japan. 1985; 169, Ref. 3
   Google Scholar
• Vercellotti G.M., Hammerschmidt D.E. Human studies involving perfluorochemical emulsions. 1988; 173–183, Ref. 5
   Google Scholar
• Bruneton J.-N., Falewée M.-N., Franĉois E., Cambon P., Philip C. J., Riess G., Balu-Maestro C., Rogopoulos A. Liver, spleen, and vessels: Preliminary clinical results of CT with perfluorooctylbromidc. Radiology 1989; 170: 179–183
   PubMed Web of Science ®Google Scholar
• Behan M.D., O'Connel R., Mattrey F., Carney D. N. Perfluorooctylbromide as a contrast agent for sonography and computed tomography, submitted to. Invest. Radiol. 1991
   Google Scholar
• Vercellotti G. M., Hammerschmidt D. E. Immunological biocompatibility in blood substitutes. 1985; 47–62, Ref. 3
   Google Scholar
• Hong F., Shastri K.A., Logue G.L., Spaulding M.B. Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies. Transfusion 1991; 31: 642–647
   PubMed Web of Science ®Google Scholar
• Faithfull N. S., Marshall H. W. The effect of fluorocarbon emulsion on placental insufficiency. Adv. Exp. Med. Biol. 1989; 248: 357–369
   PubMedGoogle Scholar
• Bentley P.K., Davis S.S., Johnson O.L., Lowe K.C., Washington C. Purification of Pluronic F-68 for perfluorochemical emulsiflcation. J. Pharm. Pharmac. 1989; 41: 661–663
   PubMed Web of Science ®Google Scholar
• Hammerschmidt D. E., Vercellotti G. M. Limitation of complement activation by perfluorocarbon emulsions: Superiority of lecithin-emulsified preparations. 1989; 431–438, Ref. 1
   Google Scholar
• Smith D. J., Lane T. A. Effect of high concentration PFOB emulsion on platelet function. These Proceedings, ISBS 1991
   Google Scholar
• Tsai A. G., Nolle D., Messmer K., Intaghetta M. Errect or Oxygent™ (perflubron emulsion) on leukocyte-endothelial interaction in post-capillary venules. These Proceedings
   Google Scholar
• Lutz J., Augustin A.J., Purucker E., Milz J. Combination of treatment with perfluorochemicals and free radical scavengers. These Proceedings, ISBS 1991; 423, Abstracts
   Google Scholar
• Flaim S.F., Hazard D. R., Hogan J., Peters R. M. Characterization and mechanism of side-effects of Oxygent™ HT (highly concentrated fluorocarbon emulsion) in swine. These Proceedings, ISBS 1991; 383, Abstracts
   Google Scholar
• Ogilby J. D., Noma S., Diloretto G., Stets G. Preservation of myocardial function during ischemia with intracoronary Oxygent. These Proceedings, ISBS 1991; 458, Abstracts
   Google Scholar
• Virmani R., Warren D., Rees R., Fink L.M., English D. Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion 1983; 23: 512–515
   PubMed Web of Science ®Google Scholar
• Ohyanagi H., Mitsuno T., Uchida T., Watanabe M., Yamanouchi K., Yokoyama K., Saitoh Y. Extended uses of Fluosol emulsion in acute myocardial ischemia treatments—experimental studies for rationale. These Proceedings, ISBS 1991; 459, Abstracts
   Google Scholar
• , Alliance Pharmaceutical Corp. (data on file).
   Google Scholar
• Martin S. M., Laks D. H.C., Drinkwater D. G., Stein S. W., Barthel E. R., Capouya J. M., Pearl B. H., Chang P. Perfluorochemical reperfusion limits myocardial reperfusion injury and improves ATP regeneration. These Proceedings, ISBS 1991; 429, Abstracts
   Google Scholar
• Martin S.M., Stein D.G., Laks H., Drinkwater D.C., Capouya E.R., Barthel S.W., Chang P. Amino acid-enriched perfluorochemical cardioplegia reperfusion improves myocardial recovery after prolonger hypothermic global ischemia, in press
   Google Scholar
• Acar C., Partington M.T., Buckberg G. D. Studies of controlled reperfusion after ischemia. J. Thorac. Cardiovasc. Surg. 1991; 101: 284–293
   PubMedGoogle Scholar
• Clark L. C., Jr., Spokane R.B., Hoffmann R. E., Sudan R., Homan M.M., Maloney A.C., Jacobs S.J., Stroup T.L., Winston P.E. Polarographic cerebral oxygen availability, fluorocarbon blood levels and efficacy of oxygen transport by emulsions. 1989; 375–393, Ref. 1
   Google Scholar
• Harvey S.A.K., Trankina M.L., Olson M.S., Clark J. B. Fluorocarbon perfusion of the isolated rat brain: measurement of tissue spaces, EEG and oxygen uptake. Biochim. Biophys. Acta 1991; 1073: 486–492
   PubMedGoogle Scholar
• Kusske J.A., Pritz M.B., Tremper K. K. Perfluorochemical emulsions for the treatment of cerebral ischemia. 1985; 131–139, Ref. 3
   Google Scholar
• Bell R.D., Frazer G.D., Osterholm J.O., Duckett S. W. A novel treatment for ischemic intracranial hypertension in cats. Stroke 1991; 22: 80–83; 2878
   PubMed Web of Science ®Google Scholar
• Del A. J., Rossi A. C., Cemaianu J. H., Cilley R., Spence K., Camishion R. C. Preventive effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. These Proceedings, ISBS 1991; 374, Abstracts
   Google Scholar
• Teicher B. A. Use of perfluorochemical emulsions in cancer therapy. These Proceedings, ISBS 1991; 490, Abstracts
   Google Scholar
• Teicher B.A., Herman T.S., Tanaka J., Eder J.P., Holden S.A., Bubley G., Coleman C.N., Frei E., III. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Cancer Res. 1991; 51: 1086–1091
   PubMed Web of Science ®Google Scholar
• Chaplin D.J., Horsman M.R., Aoki D. S. Nicotinamide, Fluosol DA and carbogen: A strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br. J. Cancer 1991; 63: 109–113
   PubMed Web of Science ®Google Scholar
• Guichard M. The use of fluorocarbon emulsions in cancer radiotherapy. Radiother. Oncol. 1991; 59–64, Suppl. 20
   PubMed Web of Science ®Google Scholar
• Dowling S., Fischer J.J., Rockwell S. A clinical study of FLuosol and hyperbaric oxygen as an adjunct to radiation therapy. These Proceedings, ISBS 1991; 377, Abstracts
   Google Scholar
• Rockwell S.M., Kelley C.G., Irvin C.S., Hughes Yabuki H., Porter E., Fischer J.J. Preclinical evaluations of a perfluorooctylbromide emulsion as an adjunct to radiotherapy. These Proceedings, ISBS 1991; 476, Abstracts
   Google Scholar
• Lartigau E., Ch. Thomas G., LeBlanc M., Riess J., Long D.C., Long E., Malaise P., Guichard M. New High O2 carrying perfluorochemical emulsions: Toxicity, radiosensitivity of GM-CFC and development of metastases in mice. Int. J. Radiation Oncol. Biol. Phys. 1989; 16: 1153–1156
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A. Enhancement of radiation therapy by an experimental concentrated perfluorooctylbromide (Oxygent) emulsion in the Lewis lung carcinoma. These Proceedings, ISBS 1991; 395, Abstracts
   Google Scholar
• Holden S.A., Teicher B.A., Herman T.S. Effect of a PFOB emulsion (Oxygent) and carbogen breathing on the tumor cell survival of the FSallC fibrosarcoma after treatment with antitumor alkylating agents. These Proceedings, ISBS 1991; 399, Abstracts
   Google Scholar
• Thomas C., Riess J.G., Guichard M. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity. Int. J. Radiat. Biol. 1991; 59: 433–445
   PubMed Web of Science ®Google Scholar
• Lowe K.C., Akande S.L., Bonnett R., White R.D., Berenbaum M. C. Protective effects of emulsified perfluorochemicals in experimental photodynamic therapy. These Proceedings, ISBS 1991; 420, Abstracts
   Google Scholar
• Wolfson M. R., Shaffer T. H. Liquid ventilation during early development: theory, physiologic processes and application. J. Devel. Physiol. 1990; 13: 1–12
   PubMedGoogle Scholar
• Greenspan J.S., Wolfson M.R., Rubenstein D., Shaffer T. H. Liquid ventilation of human preterm neonates. J. Pediatrics 1990; 117: 106–111
   PubMed Web of Science ®Google Scholar
• Fuhrman B.P. Perfluorocarbon liquid ventilation: The first human trial. ibid 1990; 73–74, (Editorial)
   Google Scholar
• Curtis S.E., Fuhrman B.P., Howland D.F., DeFrancisis M., Motoyama E.K. Cardiac output during liquid (perfluorocarbon) breathing in newborn piglets. Crit. Car Med. 1991; 19: 225–230
   PubMed Web of Science ®Google Scholar
• Lachmann B., Tütüncü A.S., Bos J.A.H., Faithfull N.S., Erdmann W. Perfluorooctylbromide (perflubron) instillation combined with mechanical ventilation: an alternative treatment of acute respiratory failure in adult animals. Oxygen Transport to Tissues XIV, W. Erdmann, D.F. Bruley. Plenum Publ. Corp., New York, in press
   Google Scholar
• Wolfson M.R., Greenspan J.S., Shaffer T. H. Pulmonary administration of vasoactive drugs (PAD) by perfluorocarbon liquid ventilation. Proc. Am Soc. Pediatr. Res. 1991
   Google Scholar
• Clark L. C., Jr, Hoffmann R.E., Davis S. L. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes. Biomat., Art. Cells, Immob. Biotech. 1991; 19: 370
   Google Scholar
• Mattrey R. F. Perfluorooctylbromide: A new contrast agent for CT, sonography and MR imaging. Am. J. Radiology 1989; 152: 247–252
   Google Scholar
• Mattrey R.F., Schumacher D.J., Tran H.T., Guo Q., Buxton R.B. The use of Imagent BP (PFOB) in diagnostic imaging and F-19 magnetic resonance for PO2 measurements. These Proceedings. ISBS 1991; 435, Abstracts
   Google Scholar
• Rubin D.L., Muller H.H., Nino-Murcia M., Sidhu M., Christy V., Young S.W. Intraluminal contrast enhancement and MR visualization of the bowel wall: Efficacy of PFOB. J. Mag. Res. Imag. 1991; 1: 371–380
   PubMed Web of Science ®Google Scholar
• King C.P., Ho-Tai P.C.K. The search for the ideal enteric MR contrast agent. Diagnost. Imaging March, 1990; 110–114
   Google Scholar
• André M., Nelson T., Mattrey R. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent. Invest. Radiol. 1990; 25: 983–987
   PubMed Web of Science ®Google Scholar
• Coley B.D., Mattrey R.F., Roberts A., Keane S. Potential role of PFOB emhanced sonography of the kidney. II. Detection of partial infarction. Kidney Intl. 1990; 39: 740–745
   Web of Science ®Google Scholar
• Munzing D., Mattrey R.F., Reznik V.M., Mitten R.M., Peterson T. Potential role of PROB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necroses. Kidney Intl. 1991; 39: 733–739
   PubMed Web of Science ®Google Scholar
• Mattrey R.F., Brown J.F., Shelton R.E., Ogino M.T., Johnson K.K., Mitten R.M. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography: safety and efficacy. Invest. Radiol. 1991; 26: 792–798
   PubMed Web of Science ®Google Scholar
• Wolf G. L., Long D., Riess J. G. Percutaneous lymphography with PFOB emulsions (Abstract). Radiol. Soc. North Amer. Chicago. 1990
   Google Scholar
• Pratt R.G., Thomas S.R., Millard R.W., Samaratunga R.C., Naseem M. H. Quantitation of perfluorocarbon blood substitutes in tissues using F-19 magnetic resonance spectroscopy. These Proceedings, ISBS 1991; 466, Abstracts
   Google Scholar
• Bömert P., Dreher W., Schneider W. 19F chemical shift imaging in perfluorocarbons. NMR in Biomed. 1989; 2: 278–283
   PubMedGoogle Scholar
• Mason R. P., Shukla H., Antich P. P. Oxygent™: A novel probe of tissue oxygen tension. These Proceedings, ISBS 1991; 430, Abstracts
   Google Scholar
• Ceckler T.L., Gibson S.L., Hilf R., Bryant R. In situ assessment of tumor vascularity using fluorine NMR imaging. Magn. Res. Med. 1990; 13: 416–433
   PubMed Web of Science ®Google Scholar
• Thomas C., Counsell C., Wood P., Adams G. E. Relative change in blood volume following vasoactive agent administration as monitored by 19F NMR spectroscopy. Int. J. Radial. Biol. 1991; 60: 219–223
   PubMed Web of Science ®Google Scholar
• Klein J., Faithfull N.S., Salt P.J., Trouwborst A. Transperitoneal oxygenation with fluorocarbons. Anesth. Analg. 1986; 65: 734–738
   PubMed Web of Science ®Google Scholar
• Hui-Sun Chen, Nan Xiao. Protection of perfluorocarbon blood substitute (PFBS) by enteral administration on superior mesentric artery occlusion (SMAO) shock in rabbit. These Proceedings, ISBS 1991; 369, Abstracts
   Google Scholar
• Ricci J.L., Sloviter H.A., Ziegler M. M. Intestinal ischemia: Reduction of mortality utilizing intraluminal perfluorochemical. Am. J. Surg. 1985; 149: 84–90
   PubMed Web of Science ®Google Scholar
• Lutz J., Herrmann G. Perfluorochemicals as a treatment of decompression sickness in rats. Pflügers Arch. 1984; 401: 174–177
   PubMed Web of Science ®Google Scholar
• Spiess B.D., McCarthy R.J., Tuman K.J., Wornowicz A.W., Tool K.A., Ivankovich A. D. Treatment of decompression sickness with perfluorocarbon emulsion (FC-43). Undersea Biomed. Res. 1988; 15: 31–37
   PubMedGoogle Scholar
• Menasche P.E., Pinard A.M., Desroches Seylaz J.P., Laget R., Geyer P., Piwnica A. Ann. Thorac. Surg. 1985; 40: 494
   PubMed Web of Science ®Google Scholar
• Fuchinoue S., Takahashi K., Teraoka S., Toma H., Ashishi T., Ota K. Clinical experience in kidney preservation with a new fluorocarbon emulsion perfusate. Transplant. Proc. 1986; 18: 566–570
   Web of Science ®Google Scholar
• Zhang R., Xiong R.C., Su B.J., et al. Phamacological study and clinical application of fluorocarbon artifical blood. Chin. J. Surg. 1985; 23: 395
   PubMedGoogle Scholar
• Urushihara T., Sumimotp K., Ikeda M., Yamanaka K., Ito H., Fukuda Y., Dohi K. 72-hour rat pancreas preservation using perfluorochemical. These Proceedings, ISBS 1991; 369, Abstracts
   Google Scholar
• Kurki T.S., Harjula A.L., Heikkilä L.S., Lehtola A.L., Pekka Hämmäinen, Taskinen E., Manila S. P. Single-lung allotransplantation in pigs: Effects of two preservation methods on pulmonary gas exchange. J. Heart Transpl. 1990; 9: 424–428
   PubMedGoogle Scholar
• Palombo J.D., Pomposelli J.J., Fechner K.D., Blackburn G.L., Bistrian B. R. Enhanced restoration of adenine nucleotides in rat liver following extended preservation in UW solution by provision of adenosine during reperfusion. Transplantation 1991; 51: 867–873
   PubMed Web of Science ®Google Scholar
• Yamamoto N., Konishi Y., Washida M., Wakashiro S., Takayasu T., Tatsumi Y., Shimahara Y., Tanaka K., Yamaoka Y., Ozawa K. Energy metabolism of porcine liver during a 72-hour hypothennic perfusion with UW solution. Eur. Surg. Res. 1991; 23: 27–34
   PubMed Web of Science ®Google Scholar
• Smith A.R., van Alphen W., Faithfull N.S., Fennema M. Limb preservation in replantation surgery. J. Plast. Reconstr. Surg. 1985; 75: 227–237
   PubMed Web of Science ®Google Scholar
• Chang S.V., Reppucci N.L., Zimmerman M., Heinemann H., Coleman D.J. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology 1989; 96: 785–792
   PubMed Web of Science ®Google Scholar
• Blinder K.J., Peyman G.A., Paris C.J., Dailey J.P., Alturki W.K.-R., Lui C.M., Gremillion L., Jr, Clark C., Jr. Vitreon, a new perfluorocarbon. Brit. J. Ophthalmol. 1991; 75: 240–244
   PubMed Web of Science ®Google Scholar
• Mattiasson B., Adlercreutz P. Perfluorochemicals in biotechnology. Tibtech 1987; 5: 250–254
   Web of Science ®Google Scholar
• King A.T., Mulligan B.J., Lowe K. C. Perfluorochemicals for gas transport and improvement of cell cultures. Oxygen Transport to Tissue XII. Plenum Press, New York 1990; 283–290
   Google Scholar
• Ceeschlin C., Malet-Martino M.C., Michel G., Lattes A. Optimization of anaerobes growth with a perfluorinated oil. Comptes Rendus Mad. Sci. 1985; 300: 669–672
   PubMed Web of Science ®Google Scholar